Physician

Robert Denison Griffith, M.D.

According to 2025 Medicare claims, Robert Griffith, M.D. (NPI: 1619235355) practices dermatology in the Knoxville, TN market, with the plurality of this provider's patient population coming from Knox, TN. This provider's primary affiliated billing organization is ROBERT CARL GRIFFITH MD (NPI: 1740752906; TIN: 621006372) and primary practice location at 37919-4900.

Griffith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 941 traditional Medicare patients, billed 9,138 HCPCS/CPT codes, and received $872,081 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,737 prescription claims across 1,014 beneficiaries totaling $441,313 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 156 records totaling $3,018. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $33,552 to $872,081. Similarly, Part D prescription costs have risen steadily, from $2,550 to $441,313. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$449K$899K2018 Medicare payment: $33,552 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $279,477 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $385,594 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $739,046 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $898,544 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $762,553 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $872,081 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018122684$33,552
20195083,867$279,477
20205134,581$385,594
20215727,211$739,046
20227018,935$898,544
20238968,854$762,553
20249419,138$872,081

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$221K$441K2015 Drug cost: $2,550 (USD; Tot_Drug_Cst)2016 Drug cost: $30,250 (USD; Tot_Drug_Cst)2017 Drug cost: $11,103 (USD; Tot_Drug_Cst)2018 Drug cost: $101,208 (USD; Tot_Drug_Cst)2019 Drug cost: $79,798 (USD; Tot_Drug_Cst)2020 Drug cost: $244,719 (USD; Tot_Drug_Cst)2021 Drug cost: $152,174 (USD; Tot_Drug_Cst)2022 Drug cost: $279,557 (USD; Tot_Drug_Cst)2023 Drug cost: $253,807 (USD; Tot_Drug_Cst)2024 Drug cost: $441,313 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151527$2,550
201646148$30,250
20172264$11,103
20185291$101,208
2019392802$79,798
20205571,600$244,719
20216171,546$152,174
20227301,830$279,557
20239122,439$253,807
20241,0142,737$441,313

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more546863$86
17110Destruction of skin growth, 1-14 growths468741$70
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more388616$61
11102Biopsy of related skin growth, first growth355473$46
17000Destruction of precancer skin growth, 1 growth464631$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept13364$95,170
Dupixent PenDupilumab16434$70,319
Clobetasol PropionateClobetasol Propionate2126,060$8,883
MupirocinMupirocin65114,235$4,397
Triamcinolone AcetonideTriamcinolone Acetonide30210,162$3,951

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.156$3,018SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Robert Denison Griffith, M.D.?

Tedicare shows public-source Medicare data for Robert Denison Griffith, M.D. (NPI 1619235355), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Denison Griffith, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert Denison Griffith, M.D.?

Robert Denison Griffith, M.D. is linked to ROBERT CARL GRIFFITH MD (billing NPI 1740752906) in the available physician profile data.

Does Robert Denison Griffith, M.D. have Open Payments data?

Robert Denison Griffith, M.D. has 156 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.